Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “labelled”
Phase I/II, Open-label, Multi-center, Two Part Dose-escalation, Safety, Pharmacokinetics (PK) and Efficacy Study of AZD4877 in Patients With Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT00486265. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia
ClinicalTrials.gov study NCT00288509. IPD Sharing: YES. Countries: 2. Publications: 2.
Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered in Participants With B-cell NHL
ClinicalTrials.gov study NCT02151903. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
ClinicalTrials.gov study NCT00422201. IPD Sharing: Not stated. Countries: 5. Publications: 3.
Open-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple Sclerosis
ClinicalTrials.gov study NCT01480076. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Efficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload and a One Year Open-label Extension Study
ClinicalTrials.gov study NCT00873041. IPD Sharing: Not stated. Countries: 9. Publications: 2.
An Open-label, Dose Escalation Study in Japanese Participants With Relapsed/Refractory Multiple Myeloma Who Have Failed Prior Anti Myeloma Treatments
ClinicalTrials.gov study NCT03828292. IPD Sharing: NO. Countries: 1. Publications: 1.
A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD)
ClinicalTrials.gov study NCT00644358. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
ClinicalTrials.gov study NCT01710709. IPD Sharing: Not stated. Countries: 10. Publications: 1.
An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complemen
ClinicalTrials.gov study NCT05514873. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant Asthma
ClinicalTrials.gov study NCT03358147. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain
ClinicalTrials.gov study NCT00487435. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension
ClinicalTrials.gov study NCT03504917. IPD Sharing: Not stated. Countries: 6. Publications: 2.
Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia
ClinicalTrials.gov study NCT05128162. IPD Sharing: NO. Countries: 1. Publications: 1.
Gel-200 Extension and Open-Label Study in Osteoarthritis of the Knee
ClinicalTrials.gov study NCT00450112. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Trial to Evaluate Safety and Efficacy of Elamipretide Primary Mitochondrial Myopathy Followed by Open-Label Extension
ClinicalTrials.gov study NCT03323749. IPD Sharing: Not stated. Countries: 7. Publications: 2.
An Open Label Trial of TMS Therapy for Bipolar Depression
ClinicalTrials.gov study NCT02640950. IPD Sharing: NO. Countries: 1. Publications: 1.
An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)
ClinicalTrials.gov study NCT04145531. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C
ClinicalTrials.gov study NCT01532908. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Transcranial Photobiomodulation for Reducing Autism Symptoms in Children - Open Label Study (TPBMASDOL)
ClinicalTrials.gov study NCT06359080. IPD Sharing: NO. Countries: 1. Publications: 6.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.